uridine diphosphate glucose has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, CB; Barrett, MO; Harden, TK; Jacobson, KA; Jayasekara, PS; Lazarowski, ER; Sesma, JI | 1 |
1 other study(ies) available for uridine diphosphate glucose and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Cell Line, Tumor; Chemotaxis; CHO Cells; Cricetinae; Glioma; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Neutrophils; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Uridine Diphosphate Glucose | 2013 |